Last update:

Immunology news

Diseases, Conditions, Syndromes

Antiviral-resistant variants of SARS-CoV-2 can emerge in immunocompromised people

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found researchers at Weill ...

Oncology & Cancer

Lowering cancer drug dose could open tumors to immunotherapy

Research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the tumor's response to immunotherapy.

Oncology & Cancer

From new treatments to AI: advances in the fight against cancer

From combining treatments in unprecedented ways to deploying artificial intelligence for personalized medicine, a raft of new advances in the fight against cancer have been presented at the European Society for Medical Oncology ...

Oncology & Cancer

Reprogramming cancer cells to attack themselves

A team of health and medical researchers affiliated with a host of institutions across Sweden has tested the possibility of reprogramming cancer cells into cDC1 cells as a means for destroying the protective shield around ...

Immunology

Mucin gel may help disk herniation patients after surgery

Researchers at Uppsala University have developed a gel inspired by cow slime for patients suffering from disk herniation. By adding the mucin gel immediately after surgery, it is possible to create a protective barrier around ...

Diseases, Conditions, Syndromes

Neoself-antigens found to induce autoimmune response in lupus

Autoimmune diseases are widespread and notoriously difficult to treat. In part, this is because why the immune system attacks its own tissues in patients with these conditions remains poorly understood.

Oncology & Cancer

How the immune system fails as cancer arises

Cancer has been described as "a wound that does not heal," implying that the immune system is unable to wipe out invading tumor cells. A new discovery confirms that a key molecule can reprogram immune cells that normally ...

Oncology & Cancer

Overcoming the limits of immunotherapies

CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the U.S. and a year later in Europe for treating acute lymphoblastic ...

Diseases, Conditions, Syndromes

T-cells with a license to kill viruses

A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.

Oncology & Cancer

New study shows polymersomes' potential in cancer immunotherapy

Within an international collaboration of 30 scientists, TU/e professors Jan van Hest and Willem Mulder are working on nanotechnological research to accurately stimulate the immune system. The TU/e team is focusing on the ...

Health

Researchers warn of allergy risks from insect-based foods

James Cook University researchers say food derived from crickets and flies can cause allergic reactions in people with existing shellfish allergy—and this is not consistently picked up by currently available testing methods. ...

Diseases, Conditions, Syndromes

Calculate your personal long COVID risk

The University of Queensland-led and developed COVID-19 Risk Calculator has been updated to determine a person's risk of developing long COVID.